Skip to main content
. 2005 Apr 13;113(8):926–933. doi: 10.1289/ehp.7713

Table 1.

Biased outcome due to source of funding in low-dose in vivo BPA research as of December 2004.

All studies
CD-SD rat studies
All studies except CD-SD rats
Source of funding Harm No harm Harm No harm Harm No harm
Government 94 (90.4) 10 (9.6) 0 (0%) 6 (100) 94 (96) 4 (4)
Chemical corporations 0 (0) 11 (100) 0 (0%) 3 (100) 0 (0) 8 (100)

Values shown are no. (%).